Anne Gussow

Array ( [id] => 5887745 [patent_doc_number] => 20060275330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Pygopus in diagnosis and treatment of cancer' [patent_app_type] => utility [patent_app_number] => 10/553661 [patent_app_country] => US [patent_app_date] => 2004-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 25985 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275330.pdf [firstpage_image] =>[orig_patent_app_number] => 10553661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4463061 [patent_doc_number] => 07935346 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-03 [patent_title] => 'Medicament for the two-step perioperative therapy of solid tumours' [patent_app_type] => utility [patent_app_number] => 10/554410 [patent_app_country] => US [patent_app_date] => 2004-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2932 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/935/07935346.pdf [firstpage_image] =>[orig_patent_app_number] => 10554410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5850617 [patent_doc_number] => 20060233808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Peptabody for cancer treatment' [patent_app_type] => utility [patent_app_number] => 10/551977 [patent_app_country] => US [patent_app_date] => 2004-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 16127 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20060233808.pdf [firstpage_image] =>[orig_patent_app_number] => 10551977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5141340 [patent_doc_number] => 20070003556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Modified antibodies against cd22 and utilization thereof' [patent_app_type] => utility [patent_app_number] => 10/550934 [patent_app_country] => US [patent_app_date] => 2004-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8048 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20070003556.pdf [firstpage_image] =>[orig_patent_app_number] => 10550934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4995085 [patent_doc_number] => 20070010430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Proteoglycan isolated from cartilaginous fish and process for producing the same' [patent_app_type] => utility [patent_app_number] => 10/574400 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9496 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20070010430.pdf [firstpage_image] =>[orig_patent_app_number] => 10574400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 588722 [patent_doc_number] => 07435590 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-14 [patent_title] => 'Monoclonal antibody and hybridoma producing the same' [patent_app_type] => utility [patent_app_number] => 10/548591 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5670 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/435/07435590.pdf [firstpage_image] =>[orig_patent_app_number] => 10548591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4497502 [patent_doc_number] => 07947812 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-24 [patent_title] => 'Neoplasm specific antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/549052 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 16720 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/947/07947812.pdf [firstpage_image] =>[orig_patent_app_number] => 10549052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5595776 [patent_doc_number] => 20060159692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Transcriptional factor inducing apoptosis in cancer cell' [patent_app_type] => utility [patent_app_number] => 10/546829 [patent_app_country] => US [patent_app_date] => 2004-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 2889 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20060159692.pdf [firstpage_image] =>[orig_patent_app_number] => 10546829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5851046 [patent_doc_number] => 20060234237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators' [patent_app_type] => utility [patent_app_number] => 10/541749 [patent_app_country] => US [patent_app_date] => 2004-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 23775 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234237.pdf [firstpage_image] =>[orig_patent_app_number] => 10541749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7082679 [patent_doc_number] => 20050048059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Therapeutic binding agents against MUC-1 antigen and methods for their use' [patent_app_type] => utility [patent_app_number] => 10/754089 [patent_app_country] => US [patent_app_date] => 2004-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10628 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048059.pdf [firstpage_image] =>[orig_patent_app_number] => 10754089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4515857 [patent_doc_number] => 07910711 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-22 [patent_title] => 'Human cancer-relating genes, the products encoded thereby and applications thereof' [patent_app_type] => utility [patent_app_number] => 10/540539 [patent_app_country] => US [patent_app_date] => 2003-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 26 [patent_no_of_words] => 9449 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/910/07910711.pdf [firstpage_image] =>[orig_patent_app_number] => 10540539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5732276 [patent_doc_number] => 20060257393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Method for protecting thiol group of protein' [patent_app_type] => utility [patent_app_number] => 10/539756 [patent_app_country] => US [patent_app_date] => 2003-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7797 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257393.pdf [firstpage_image] =>[orig_patent_app_number] => 10539756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4629380 [patent_doc_number] => 08008266 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-30 [patent_title] => 'Methods of treating cancer using immunostimulatory oligonucleotides' [patent_app_type] => utility [patent_app_number] => 10/719493 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 26780 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/008/08008266.pdf [firstpage_image] =>[orig_patent_app_number] => 10719493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 33138 [patent_doc_number] => 07790866 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-07 [patent_title] => 'Cancer-associated gene' [patent_app_type] => utility [patent_app_number] => 10/535733 [patent_app_country] => US [patent_app_date] => 2003-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17095 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/790/07790866.pdf [firstpage_image] =>[orig_patent_app_number] => 10535733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 840297 [patent_doc_number] => 07390625 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-24 [patent_title] => 'Apoptosis-associated protein and use thereof' [patent_app_type] => utility [patent_app_number] => 10/535931 [patent_app_country] => US [patent_app_date] => 2003-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 37424 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/390/07390625.pdf [firstpage_image] =>[orig_patent_app_number] => 10535931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5857838 [patent_doc_number] => 20060228326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Active specific immunotherapy of cancer metastasis' [patent_app_type] => utility [patent_app_number] => 10/532551 [patent_app_country] => US [patent_app_date] => 2003-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 21215 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20060228326.pdf [firstpage_image] =>[orig_patent_app_number] => 10532551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8114347 [patent_doc_number] => 08158385 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-17 [patent_title] => 'Cell death-inducing agent' [patent_app_type] => utility [patent_app_number] => 10/530696 [patent_app_country] => US [patent_app_date] => 2003-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 51 [patent_no_of_words] => 15532 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/158/08158385.pdf [firstpage_image] =>[orig_patent_app_number] => 10530696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7286925 [patent_doc_number] => 20040146938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Methods of generating and screening for proteases with altered specificity' [patent_app_type] => new [patent_app_number] => 10/677977 [patent_app_country] => US [patent_app_date] => 2003-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20895 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20040146938.pdf [firstpage_image] =>[orig_patent_app_number] => 10677977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5100708 [patent_doc_number] => 20070183970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Chimeric, human and humanized anti-granulocyte antibodies and methods of use' [patent_app_type] => utility [patent_app_number] => 10/672278 [patent_app_country] => US [patent_app_date] => 2003-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 38809 [patent_no_of_claims] => 106 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20070183970.pdf [firstpage_image] =>[orig_patent_app_number] => 10672278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7675327 [patent_doc_number] => 20040126791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Compositions and methods for treating trail-resistant cancer cells' [patent_app_type] => new [patent_app_number] => 10/666458 [patent_app_country] => US [patent_app_date] => 2003-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11695 [patent_no_of_claims] => 96 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0126/20040126791.pdf [firstpage_image] =>[orig_patent_app_number] => 10666458 [rel_patent_id] =>[rel_patent_doc_number] =>)